CONRAY (iothalamate meglumine) by Guerbet is clinical pharmacology following intravascular injection, conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. First approved in 1962.
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
CONRAY (iothalamate meglumine) is an iodinated contrast medium administered by injection for radiographic visualization of vascular, renal, and CNS structures. It works by rapidly distributing through the circulatory system and accumulating in target tissues, providing diagnostic opacification through its high iodine content. The drug is excreted unchanged primarily via glomerular filtration, with renal accumulation occurring within 3–8 minutes of injection.
As a legacy diagnostic contrast agent approaching loss of exclusivity with low linked job count, commercial teams are likely minimal and focused on managed decline rather than growth initiatives.
CLINICAL PHARMACOLOGY Following intravascular injection, Conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. The pharmacokinetics of intravascularly administered radiopaque contrast media are usually best…
Worked on CONRAY at Guerbet? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on CONRAY offers limited career growth opportunity given its mature lifecycle and approaching loss of exclusivity, with teams primarily focused on regulatory maintenance, supply chain efficiency, and managed market transition. Roles are concentrated in operational and compliance functions rather than commercial expansion, making this assignment most suitable for consolidation or project-based expertise rather than long-term brand building.